Crossmark

Comparison in Patients’ Adherence, Adverse Effects, and Clinical Outcomes Among Liver Transplant Recipients Using Immediate-Release Tacrolimus (Prograf <sup>®</sup> ) Versus Extended-Release Tacrolimus (Advagraf <sup>®</sup> ): First Report from Iran

Crossref DOI link: https://doi.org/10.34172/aim.34896

Published Online: 2026-02-01

Published Print: 2026-02-01

Update policy: https://doi.org/10.34172/crossmark_policy

Authors

Shafiekhani, Mojtaba https://orcid.org/0000-0001-8661-1838
Mahmoudi, Mohamad Mahdi

Rostami, Hasan

Shamsaeefar, Alireza

Sohrabi Nazari, Sahar

Doostfatemeh, Marziyeh

Alishavandi, Fatemeh

Rajabian, Mohamad Sadegh

Nikoupour, Hamed https://orcid.org/0000-0003-0708-334X
More Information

Journal Owner: Academy of Medical Sciences of I.R. Iran

Journal Publisher: Academy of Medical Sciences of I.R. Iran

Publication History

Received: 2025-07-30

Accepted: 2026-01-30

Published: 2026-02-01

Document is current

Any future updates will be listed below